CHGA
Change Agents Corp.
There isn't enough reported data to score CHGA yet.
NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
CHGA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
CHGA's revenue is currently stable, but its profitability is under pressure. There isn't enough data to rate its cash flow and balance sheet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
CHGA PE Valuation
CHGA has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
CHGA Forward outlook
There aren't enough analyst estimates for CHGA to show an outlook.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
CHGA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$280.40 | +$125.00 |
| Q2 2025 | -$315.60 | +$95.40 |
| Q1 2025 | -$248.20 | +$180.80 |
| Q4 2024 | -$255.60 | +$221.40 |
| Q3 2022 | -$390.00 | -$30.00 |
| Q2 2022 | -$270.00 | +$150.00 |
| Q1 2022 | -$300.00 | +$150.00 |
| Q4 2021 | -$330.00 | +$150.00 |
NVDA has the stronger earnings trend. Trailing diluted EPS is down 169% for CHGA versus NVDA up 125%.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA's earnings per share have climbed steadily: $7.91 over the past year, up 125% from the year before, and higher year over year for 13 quarters in a row.
CHGA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2025 | $350.1K | +1.4% |
| Q2 2025 | $350.4K | +6.9% |
| Q1 2025 | $349.8K | -33% |
| Q4 2024 | $345.8K | -32% |
| Q3 2024 | $345.2K | -21% |
| Q2 2024 | $327.9K | +6.8% |
| Q1 2024 | $519K | +75% |
| Q4 2023 | $510K | +72% |
NVDA has the stronger quarterly revenue trend. Revenue is up 1.4% for CHGA versus up 106% for NVDA.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2025 | -22% | +346 points |
| Q2 2025 | -1110% | -651 points |
| Q1 2025 | -517% | -354 points |
| Q4 2024 | -379% | +1541 points |
| Q3 2024 | -368% | -108 points |
| Q2 2024 | -459% | +149 points |
| Q1 2024 | -162% | +737 points |
| Q4 2023 | -1920% | -1166 points |
CHGA's operating margin was −22% last quarter, up 346 points from the same quarter a year ago, near the top of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA's revenue has grown year over year for 13 quarters in a row: $96.2B last quarter, up 106% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA's operating margin was 66% last quarter, up 5.4 points from the same quarter a year ago, near the top of its range since 2019.
CHGA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$2.9M | -$1.1M |
| Q4 2023 | -$796.3K | +$1.2M |
| Q3 2023 | -$1.3M | +$1M |
| Q1 2023 | -$1.9M | -$1.3M |
| Q4 2022 | -$2M | -$247.3K |
| Q3 2022 | -$2.4M | -$1.7M |
| Q1 2022 | -$511.2K | +$1M |
CHGA has burned cash in almost every quarter: −$6M over the past year, against −$6M the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over CHGA on cash generation, producing positive trailing cash flow while its opponent burns cash.
CHGA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +76% | +341K shares |
| 1 year | +872% | +708K shares |
| 3 years | +2439% | +759K shares |
| 5 years | +2879% | +763K shares |
| Available history | +3031% | +764K shares |
CHGA has 789,622 diluted shares, up 872% from a year ago.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over CHGA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
CHGA Net Leverage
CHGA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CHGA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.4 | Oversold |
| Stochastic | 3.2 | Oversold |
CHGA's weekly RSI is 28 (oversold) and its Stochastic is 3 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CHGA PE vs Technology Sector
CHGA has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
CHGA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.62 | 42% below |
| 20 week MA | $2.98 | 68% below |
| 50 week MA | $9.99 | 91% below |
| 100 week MA | $37.5 | 97% below |
| 200 week MA | $158.1 | 99% below |
CHGA is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over CHGA on trend strength, trading above more of its moving averages.
CHGA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5,940.0 | $3,570.0 | -40% |
| 2021 | $3,570.0 | $2,747.0 | -23% |
| 2022 | $2,747.0 | $1,247.2 | -55% |
| 2023 | $1,247.2 | $145.0 | -88% |
| 2024 | $145.0 | $65.8 | -55% |
| 2025 | $65.8 | $26.6 | -60% |
| 2026 YTD | $26.6 | $0.94 | -96% |
CHGA has finished every year since 2020 lower, and it's down 96% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over CHGA on returns for 2026, with the stronger performance.